Yousif Capital Management LLC Sells 8,267 Shares of Albemarle Co. (NYSE:ALB)

Yousif Capital Management LLC decreased its position in shares of Albemarle Co. (NYSE:ALB) by 10.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 73,270 shares of the specialty chemicals company’s stock after selling 8,267 shares during the quarter. Yousif Capital Management LLC owned approximately 0.06% of Albemarle worth $6,307,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its stake in shares of Albemarle by 3.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,832 shares of the specialty chemicals company’s stock valued at $268,000 after purchasing an additional 102 shares during the period. TD Private Client Wealth LLC raised its holdings in Albemarle by 50.4% in the third quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 132 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in Albemarle by 48.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company’s stock valued at $36,000 after buying an additional 136 shares during the period. First Community Trust NA boosted its holdings in shares of Albemarle by 55.0% during the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 142 shares in the last quarter. Finally, abrdn plc grew its position in shares of Albemarle by 0.3% in the 3rd quarter. abrdn plc now owns 42,529 shares of the specialty chemicals company’s stock worth $4,031,000 after buying an additional 146 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Trading Down 1.1 %

Shares of Albemarle stock opened at $78.99 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.44 and a quick ratio of 1.58. The stock has a market capitalization of $9.28 billion, a PE ratio of -4.72, a P/E/G ratio of 3.65 and a beta of 1.59. Albemarle Co. has a 1-year low of $71.97 and a 1-year high of $143.19. The company’s fifty day simple moving average is $92.52 and its 200-day simple moving average is $92.92.

Insider Activity at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of Albemarle stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $101.12, for a total transaction of $255,328.00. Following the transaction, the chief executive officer now directly owns 73,747 shares of the company’s stock, valued at $7,457,296.64. The trade was a 3.31 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.38% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Clarkson Capital initiated coverage on shares of Albemarle in a research note on Tuesday, January 14th. They set a “buy” rating and a $112.00 price objective on the stock. Mizuho cut their price target on Albemarle from $110.00 to $105.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Truist Financial began coverage on Albemarle in a research note on Tuesday, January 28th. They set a “hold” rating and a $96.00 price objective for the company. Robert W. Baird increased their target price on Albemarle from $79.00 to $103.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 18th. Finally, Oppenheimer lowered their price target on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Albemarle presently has an average rating of “Hold” and a consensus target price of $113.95.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.